|
|
What's New
last updated 10/21/02
There are a number of studies that are in development and soon to be opened
to enrollment. We will keep this page updated and it will provide information
about the opening of these studies. The projected opening dates are in
red. Please visit this page often as it will include all of the latest
studies.
| A5119
- 11/2002 |
The
Pharmacokinetic Interaction between Selected Protease Inhibitors
or Efavirenz and Hormone
Replacement Therapy (HRT) in HIV-Infected
Postmenopausal Women |
| A5135
- 11/2002 |
A
Phase II, Randomized, Open-Label, Pilot Study Comparison of
Fixed-Dose Versus Concentration-Adjusted Protease Inhibitor Therapy
in HIV-Infected Subjects on Salvage Therapy |
| A5142
- 11/2002 |
Phase
III, Randomized, Open-Label Comparison of Lopinavir/Ritonavir
plus Efavirenz vs. Lopinavir/Ritonavir plus Stavudine (or Ziduvudine)
and Lamivudine vs. Efavirenz plus Stavudine (or Zidovudine) and Lamivudine
for Initial Therapy of HIV-1 Infection |
| A5150
- 11/2002 |
A
Prospective Observational Study of Virologic and Immunologic
Changes in HIV-Infected Women during the Postpartum Period |
|
